Endocrinology, Vol 128, 1419-1424, Copyright © 1991 by Endocrine Society

ARTICLES

Interactions between steroid hormones and insulin-like growth factor-I in rabbit chondrocytes

Y Itagane, H Inada, K Fujita and G Isshiki
Department of Pediatrics, Osaka City University Medical School, Japan.

The mechanism of action of steroid hormones on skeletal growth is not understood in detail. We examined the interactions of steroid hormones and insulin-like growth factor-I (IGF-I) during DNA and sulfated proteoglycan synthesis in rabbit costal chondrocytes. Progesterone at 0.05 nM stimulated the incorporation of [3H]thymidine into DNA by 30% above the control level in confluent cultures, but neither testosterone nor 17 beta-estradiol stimulated DNA synthesis. None of the hormones affected [3H]thymidine incorporation stimulated by IGF-I when chondrocytes were incubated with one of the hormones and IGF-I simultaneously. In contrast, when confluent cultures were incubated with one of the sex steroids for 24 h before the addition of IGF-I, stimulation of DNA synthesis by the growth factor was enhanced about 45% above the control value by 0.5 nM progesterone, 50% by 0.5 nM testosterone, and 80% by 50 nM 17 beta-estradiol. The effects of IGF-I on proteoglycan synthesis, as judged by the incorporation of [35S]sulfate, were stimulated by treatment with progesterone or testosterone. Dexamethasone at physiological concentrations inhibited chondrocyte DNA synthesis in confluent cultures to 10% of the control level. At 50 nM, dexamethasone suppressed IGF-I induction of DNA synthesis by 60%. This suppression was greater when dexamethasone was added before IGF-I than when the additions were simultaneous. When chondrocytes were treated with hydrocortisone or dexamethasone for 24 h before the addition of IGF-I, the glucocorticoids synergistically accelerated proteoglycan synthesis mediated by IGF-I. These findings suggest that steroid hormones have priming effects on the biological action of IGF-I in cartilage metabolism.

This article has been cited by other articles:

				T. Fukushima, T. Nedachi, H. Akizawa, M. Akahori, F. Hakuno, and S.-I. Takahashi Distinct Modes of Activation of Phosphatidylinositol 3-Kinase in Response to Cyclic Adenosine 3', 5'-Monophosphate or Insulin-Like Growth Factor I Play Different Roles in Regulation of Cyclin D1 and p27Kip1 in FRTL-5 Cells Endocrinology, July 1, 2008; 149(7): 3729 - 3742. [Abstract] [Full Text] [PDF]

				G. Verbruggen Chondroprotective drugs in degenerative joint diseases Rheumatology, February 1, 2006; 45(2): 129 - 138. [Abstract] [Full Text] [PDF]

				J Wang, D Elewaut, I Hoffman, E M Veys, and G Verbruggen Physiological levels of hydrocortisone maintain an optimal chondrocyte extracellular matrix metabolism Ann Rheum Dis, January 1, 2004; 63(1): 61 - 66. [Abstract] [Full Text] [PDF]

				B. C. J. van der Eerden, M. Karperien, and J. M. Wit Systemic and Local Regulation of the Growth Plate Endocr. Rev., December 1, 2003; 24(6): 782 - 801. [Abstract] [Full Text] [PDF]

				A. K. Harvey, X.-P. Yu, C. A. Frolik, and S. Chandrasekhar Parathyroid Hormone-(1-34) Enhances Aggrecan Synthesis via an Insulin-like Growth Factor-I Pathway J. Biol. Chem., August 13, 1999; 274(33): 23249 - 23255. [Abstract] [Full Text] [PDF]

				R. Quarto, G. Campanile, R. Cancedda, and B. Dozin Modulation of Commitment, Proliferation, and Differentiation of Chondrogenic Cells in Defined Culture Medium Endocrinology, November 1, 1997; 138(11): 4966 - 4976. [Abstract] [Full Text] [PDF]